Claret Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Claret Asset Management's IDXX Position: Q2 2026 in Review
Claret Asset Management reduced its Idexx Laboratories (IDXX) stake by 1.8% in Q2 2026, selling an estimated $4.49K and leaving 434 shares worth $229K. The position accounts for 0.02% of the portfolio, ranked #283.
Claret Asset Management first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $299K in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Claret Asset Management held 434 shares of Idexx Laboratories worth $229K as of Q2 2026.
- Claret Asset Management sold 8 Idexx Laboratories shares in Q2 2026, an estimated $4.49K.
- Idexx Laboratories made up 0.02% of Claret Asset Management's portfolio in Q2 2026, its #283 holding.
- Claret Asset Management first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
- Claret Asset Management's Idexx Laboratories position peaked at $299K in Q4 2025.
- 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.